Business Context and Reporting Period
Company: GlaxoSmithKline plc
Filing Type: Form 6-K (Report of Foreign Issuer)
Reporting Period: October 2012
Date Filed: October 15, 2012
Context: This filing reports a corporate action regarding a block listing application with the Financial Services Authority and the London Stock Exchange Plc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a notification of a share issuance application and does not contain financial performance data.
Material Changes
Share Issuance Application:
- Shares Reserved: 10,000,000 ordinary shares of 25p each.
- Purpose: Admission to the Official List via block listing for shares to be issued under the GlaxoSmithKline Share Option Plan - ADS.
- Ranking: When issued, these shares will rank pari passu with existing ordinary shares.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the administrative details of the share listing application.
Investor Verification Checklist
- Confirm the final admission of the 10,000,000 shares to the Official List.
- Verify the specific timing of the share issuance under the Share Option Plan - ADS.
- Review the impact of this issuance on total outstanding share count and potential dilution.